The effect of hysterectomy on the risk of an abnormal screening Papanicolaou test result

被引:27
作者
Fox, J
Remington, P
Layde, P
Klein, G
机构
[1] Ctr Dis Control, Epidemiol Program Off, Div Appl Publ Hlth Training, Atlanta, GA 30333 USA
[2] Med Coll Wisconsin, Dept Family & Community Med, Milwaukee, WI 53226 USA
[3] Dane Cty Cytol Ctr, Madison, WI USA
关键词
vaginal cytology; hysterectomy; screening; Papanicolaou smear;
D O I
10.1016/S0002-9378(99)70601-0
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
OBJECTIVE: Our aim was to determine the risk of cytologic abnormality on a screening Papanicolaou test for women greater than or equal to 50 years old with and without a uterine cervix. STUDY DESIGN: The effect of hysterectomy on abnormal screening Papanicolaou test rates was determined in a cross-sectional analysis of 21,152 women aged greater than or equal to 50 years who had screening Papanicolaou tests between January and August 1995. We then conducted a nested 1:1 case-control study of 172 case patients and 172 age-matched randomly selected control patients from the cohort. To control for potential confounders, conditional logistic regression was used to assess the effect of hysterectomy status on the risk of an abnormal Papanicolaou test. RESULTS: Compared with age-matched women with a uterine cervix, those who had a hysterectomy had a 10-fold lower risk of a screening Papanicolaou test abnormality (odds ratio 0.09, 95% confidence interval 0.02-0.24). The risk was further reduced among women taking estrogens (odds ratio 0.02, 95% confidence interval 0.004-0.14) compared with women not using estrogens (odds ratio 0.14, 95% confidence interval 0.04-0.56). CONCLUSIONS: The reduced risk of Papanicolaou test abnormalities among women aged greater than or equal to 50 years who have had a hysterectomy should be considered when individual patients are being counseled, screening guidelines are being formulated, and health care resources are being allocated.
引用
收藏
页码:1104 / 1109
页数:6
相关论文
共 20 条
[1]
*AM COLL OBST GYN, 1995, REC FREQ PAP SMEAR S, P112
[2]
American Cancer Society, 1991, PAP TEST
[3]
[Anonymous], 1982, CASE CONTROL STUDIES
[4]
Effectiveness of vaginal Papanicolaou smear screening after total hysterectomy for benign disease [J].
Fetters, MD ;
Fischer, G ;
Reed, BD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (12) :940-947
[5]
FISHER G, 1995, J FAM PRACTICE, V41, P16
[6]
Kurman RJ, 1994, BETHESDA SYSTEM REPO
[7]
Kvale K M, 1994, Wis Med J, V93, P275
[8]
LENINGER L, 1994, J GEN INTERN MED, V9, P88
[9]
MILLER AB, 1991, CAN MED ASSOC J, V145, P1301
[10]
THE NEED FOR PAP TESTS AFTER HYSTERECTOMY FOR BENIGN DISEASE - RESULTS OF A STUDY OF BLACK PATIENTS [J].
MILLER, JM ;
CHAMBERS, DC ;
MILLER, JM .
POSTGRADUATE MEDICINE, 1987, 82 (01) :200-&